NEW YORK (CBSNew York) – The US Prevention Services Task Force recommends a major change in the use of aspirin.
The panel now says millions of Americans taking aspirin shouldn’t take it to prevent heart disease and stroke.
But as CBS2’s Dr Max Gomez reported on Wednesday, it depends on your age and other risk factors.
BACK BACK: Study: Role of Aspirin in Treatment of Heart Attacks, Strokes May Be Harmful in Some Patients
Aspirin is a long-known blood thinner that studies show may be important in preventing heart disease and stroke, but like most things in medicine, the details make a huge difference.
Blood thinners like aspirin are valuable in prevention, as most heart disease and strokes are caused by blood clots. But aspirin can also cause serious and even fatal internal bleeding, especially bleeding in the brain called hemorrhagic strokes, and this risk increases with age.
This is why the USPST is now proposing that people over the age of 60 should not take the drug for primary prevention. In other words, if you don’t already have a history of heart disease.
“The American College of Cardiology, the American Heart Association and a strong message from the Food and Drug Administration that aspirin is not really indicated for preventing heart disease in people who don’t already have it. “said Dr. Steven Nissen of the Cleveland Clinic.
BACK BACK: HealthWatch: Aspirin may be a wonder drug, but new research suggests it’s not for everyone
The task force also changed its guidelines for people aged 40 to 59, saying only people at low risk of bleeding but whose risk of heart disease is greater than 10% over the next 10 years should consider l low-dose aspirin after consulting a doctor. their doctor.
When it comes to preventing heart disease, controlling blood pressure and cholesterol, eating healthy and exercising are just as essential.
“People want to take a little pill and solve all of their problems, when in fact, they have to do other things first,” Nissen said.
It’s important to note that these are only draft recommendations at this time, which means that a final decision has yet to be made on whether to pass them after the public comment period ends on November 8.